Woodline Partners’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $798K | Sell |
|
|||||
|
2025
Q1 | $1.13M | Buy |
|
|||||
|
2024
Q4 | $2.35M | Sell |
|
|||||
|
2024
Q3 | $10.7M | Buy |
|
|||||
|
2024
Q2 | $3.29M | Sell |
|
|||||
|
2024
Q1 | $13.9M | Buy |
|
|||||
|
2023
Q4 | $1.44M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $476K | Buy |
|
|||||
|
2023
Q1 | $570K | Sell |
|
|||||
|
2022
Q4 | $1.62M | Hold |
|
|||||
|
2022
Q3 | $3.6M | Hold |
|
|||||
|
2022
Q2 | $3.98M | Hold |
|
|||||
|
2022
Q1 | $6.23M | Sell |
|
|||||
|
2021
Q4 | $11.6M | Buy |
|
|||||
|
2021
Q3 | $9.07M | Buy |
|
|||||
|
2021
Q2 | $11.4M | Buy |
|
|||||
|
2021
Q1 | $10.4M | Buy |
|